Abstract: Medical device software development organisations are bound by regulatory requirements and constraints to ensure that developed medical devices will not harm patients. Medical devices have to be treated as complete systems and be evaluated in this manner. Instead of manufacturers having to ensure compliance to various regulatory standards individually, the authors previously developed a medical device software process assessment framework called MDevSPICE ® that integrates the regulatory requirements from all the relevant medical device software standards. MDevSPICE ® was developed in a manner that suits plan-driven software development. In order to improve the usability of MDevSPICE in agile settings, we extended the assessment approach. The hybrid assessment approach described here, combines the MDevSPICE ® based process assessment method with steps for prioritization of improvement needs through value stream mapping, and enabling process improvement through the use of KATA. This approach integrates agile methods into the medical device software development process whilst adhering to the requirements of the regulatory standards. This paper describes the implementation of the approach within four organisations that develop software in line with medical device regulations.
INTRODUCTION
Increasingly, safety-critical software systems are affecting our everyday living as more and more software is embedded into safety critical systems such as cars, trains, airplanes, and healthcare systems which include medical devices. In order to ensure the safety of such systems international standards have been developed. In order to market a medical device within a particular region, the manufacturer has to satisfy a number of regional regulatory requirements.
To assist software development organisations in the medical device domain and to achieve regulatory compliance, the authors have previously developed an integrated framework of medical device software development best practices called MDevSPICE ® [1] . MDevSPICE ® integrates generic software development best practices with medical device standards' requirements enabling robust software process assessments to be performed against an organisation's current software development practices.
MDevSPICE ® was originally designed to be used with both traditional waterfall and V-model lifecycle models. These software development life cycle models are plan-driven, rigid and sequenced which make MDevSPICE ®' s usage limited for companies which wish to adopt agile software development approaches. In order to extend the capability and usage of MDevSPICE ® , agile practices were integrated into the assessment approach.
A standard MDevSPICE ® assessment approach includes evaluation of 23 processes at the base practice level. In this paper, we describe the hybrid assessment approach, which includes value stream mappings. Additionally, it integrates agile practices into the reporting phase of an MDevSPICE assessment so that such practices can be provided to organisations within the findings report instead of purely plan driven improvement recommendations. Afterwards, we prioritise these recommendations to enable a focus to be provided to the process improvement implementation through the use of KATA [2] . We discuss how the hybrid assessment approach was implemented in four companies, three of which are from medical domain and one of them is a software development company that is planning to develop software that could in the future be classified as a medical device.
In Section 2, we provide an overview of the regulatory requirements medical device software development companies face before they are able to market their devices. In Section 3, we describe the structure of the MDevSPICE ® framework. Section 4 outlines the challenges associated with using MDevSPICE ® lessons learned when validating the framework in expert reviews and in industry through MDevSPICE ® pilot assessments. In Section 5, we present the literature review and how the perception of the use of agile software development in medical device software development has changed. In Section 6, we introduce the hybrid assessment approach for medical device software development companies. In Section 7, we present the implementation of the approach in four companies. We provide our conclusions and future research in Section 8.
REGULATIONS
In order to place a medical device on the market it is necessary to satisfy the regulatory requirements for that region. Two significant markets for medical devices are the USA and the European Union. Within the USA the FDA are responsible for issuing and managing medical device regulation. The FDA provides a number of regulatory and guidance documents in relation to medical devices, including the Code of Federal Regulation Title 21, Chapter I, Subchapter H, Part 820 [3] . In the European Union (EU), the European Commission defines directives that are then overseen by competent authorities within each of the member states.
There are a number of medical device directives: the Active Implantable MDD (AIMDD) [11] . The QMS requirements of ISO 13485 need to be adhered to in order to market a medical device in Europe. As ISO 13485 does not specifically focus upon software requirements, it may be used to support the safe design of medical device software in conjunction with IEC 62304 [8] .
IEC 62304 defines three medical device software safety classifications: Class A; Class B; and Class C. Failure of software that is of safety Class A will result in no injury or damage to the health of a patient. In the case of failure of software with a safety classification of B, non-serious injury may occur. Software with a safety Classification of C has the highest risk as in the case of failure death or serious injury may occur happen. Depending on the functionality of software within the medical device, the software safety classification may vary from the overall medical device safety class.
IEC 62304 considers a medical device to include a software component as rather than being a complete medical device system. Consequently, IEC 62304 does not consider a medical device to be formed completely of software, but rather that there are also other electronics or hardware components that together with the software form a complete medical device system. Therefore, system level requirements are not included within IEC 62304 but instead within IEC 60601-1 [12] which is a medical device system level standard. Additionally, given the increasing importance of human factors and usability within the medical device industry, organizations should also adopt IEC 62366 [13] , which outlines usability engineering requirements for the medical devices.
As a result of an amendment to the medical device directives [7] software systems that perform the functionality of a medical device (as opposed to being a component of an overall medical device) could be defined as a medical device in their own right. However, until recently international medical device standards did not address standalone software as a medical device. 
The CHALLENGES ASSOCIATED with USING MDevSPICE

®
Formal models like CMMI [22] and ISO/IEC 15504 [23] are used to promote maturity and capability in software processes. In the literature, there are very few studies discussing the challenges and successful implementations of integrating agile and formal software process improvement models [24] [25] [26] . Literature discussions are mostly shaped to answer the question of why agile and formal process improvement models do not contradict each other. Previously, it was thought by the commercial software development community that formal process improvement models and agile are at odds with each other [27, 28] . According to the Software Engineering Institute (SEI) what caused the perception of the relationship between Agile and CMMI to be like "oil and water" may be attributed to the presentation of extreme examples of both sides by early adopters, therefore providing inaccurate information about them and their misusages [27] .
In a study including 40 agile experts, composed of researchers and academics, the participants classified each CMMI component as either: (1) in conflict with; (2) of no consequence to; or (3) being supportive of agile methods in general. The results showed that the differences between the agile and formal process communities are beginning to be better articulated and better understood. It was stated that although there are significant differences between both sides, they could work together [29] .
The authors have performed many MDevSPICE ® assessments within medical device software development companies and have experienced challenges using MDevSPICE ® in Agile Software Development environments. MDevSPICE ® is designed for high-risk, safety critical systems which in the case of a software failure, could result in harm to human life. To reduce the risk associated with software failures, MDevSPICE ® favors upfront planning. This is one of the major contradictions of MDevSPICE ® with agile software development that agile methods favor an adaptive and exploratory approach through accepting that it is difficult to get requirements completely understood up-front. For example, signing off both system and software requirements before development commences is in conflict with the product backlog grooming practice in Scrum which allows you to dynamically update and re-prioritize backlog items.
Another challenge that the authors have observed was associated with the recommendations given to organisations after process assessment. As a descriptive model, MDevSPICE ® does not prescribe how to perform base practices within a specific context, however provides guidance with possible outputs of the practices. These outcomes again, are derived from formal software development life cycle models with recommendations being plan driven and formal.
Therefore, more effective ways to implement software needed to be integrated with
Additionally, companies found that MDevSPICE ® was excellent at highlighting gaps in current software development processes but that the plan-driven recommendations provided often increased the overhead associated with development. Therefore, they really would like to have been provided with more flexible recommendations that could be implemented in a much more efficient manner. Likewise, companies also found that MDevSPICE ® tended to focus more upon providing guidance in relation to strategies and plans that need to be put in place rather than providing more practical recommendations as to how this could be achieved.
AGILE USAGE in the MEDICAL DOMAIN
This section has been taken out of the pre-print version due to copy right issues. The full paper could be found at https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.
The HYBRID APPROACH
The hybrid assessment approach we discuss within this paper for medical device software development has two principal activities as shown in Figure 1 : studies in theory and studies in the field. These two studies are fed from each other. In theory, we are developing an integrated [49] in an iterative manner until all recommendations are complete.
The following sections provide details of these activities. 
Studies in Theory
One of the major components of our hybrid assessment approach is the "agile practices repository" that includes a bilateral mapping of agile practices against MDevSPICE ® 's base and specific practices. The purpose of the mapping is to understand which of the MDevSPICE ® base and specific practices could be fulfilled by adopting associated agile practices (for recommendations) and what additionally needs to be done to satisfy regulatory requirements.
We aim to extend the applicability of MDevSPICE ® in companies which follow an agile software development life cycle. We selected eXtreme programming [50] , Scrum [51] , DevOps [52] , Lean [53] , Kanban [54] , Disciplined Agile Delivery (DAD) [31] and Scaled Agile
Framework (SAFE) [55] as the source of the agile practices that we adopt. This selection was made to cover: small and large scale agile adoption (DAD and SAFE); fundamental agile methods (XP, Scrum, KanBan); and new paradigms (DevOps, Lean). For example, in Table 1 we provide a mapping between the primary practices of XP and MDevSPICE ® 's base practices. 
Studies in the Field
MDevSPICE ® Based Process Assessment: MDevSPICE ® , has been validated in the medical device industry through pilot assessments during the past four years [1, 19] . An MDevSPICE ® assessment is performed to grasp the current condition of the company and identify problems and issues regarding the medical software development life cycle. The basic MDevSPICE ® assessment process includes assessment planning, execution and reporting phases as described below. In the assessment planning phase, we decide upon the scope of the assessment. In other words which project/s to assess and the processes to be included in the assessment.
Additionally, the logistics are agreed in terms of the dates that the assessment will take place on and the company staff that will participate within the assessment.
In the execution phase, we perform interviews with the participants that were nominated for each process. One interview is performed for each process area with normally two assessors and at least one person from the company being present within each interview. During each interview, the assessors ask the company employees a comprehensive set of scripted questions that were derived from the base practices of each process by the assessment team in advance of the onsite assessment. The assessors also ask additional related questions that arise during the course of the interview to glean more information about the companies' processes. In addition to the question and answer interview session, as we are assessing medical device organisations who have to produce evidence that they have followed their processes throughout the development lifecycle, we also request them to provide us with specific evidence of their software development process such as requirements documents, design artifacts and tools that are in actual use to support the responses to their interview questions.
In the reporting phase, upon completion of the onsite execution stage, the assessment team go offsite and prepare a findings report by working together to agree upon the assessment findings including strengths, issues and recommendations. The recommendations both include agile and plan driven practices. The assessment team then return back to the assessed company and present the findings report to all participants and this acts as the first step towards improvement.
The next is to prioritize the recommendations provided in the findings report.
A) Prioritization:
After the reporting phase, we obtain a list of the issues and problems that needs to be solved to deliver products in a more efficient manner. We prefer to keep these items on an Improvement Backlog which are prioritized and dynamic like a product backlog.
Value Stream Mapping:
The reporting phase is followed by the value stream mapping study (VSM). The purpose of the value stream mapping is to visualize bottlenecks, redundancies and gaps in the value delivery system [56] . Therefore, it is very beneficial to perform this at the prioritization stage so that crucial bottlenecks can be highlighted and recommendations selected first that will enable the process to be improved in the most efficient order to remove these bottlenecks. VSM is one of the lean practices used in the Toyota Production System and was introduced by Rother and Shook [57] . The value stream is the flow of work from a customer request to the fulfillment of that request [49] . The value stream mapping is the process of identifying various process blocks at a decent level of detail within the product delivery. We utilize the value stream of a product or feature to specify where to direct our attention for process improvement. To run a value stream exercise, we interview people with responsibilities for different parts of the software development lifecycle who can authorize the process changes required to achieve an effective future-state value stream. We use three metrics within the value stream mapping study as shown in The proportion of time a process receives something from an upstream process that does not require rework
B)
Improvement KATA: One of the first steps that must be taken in software process improvement is to decide how the changes will be identified, agreed upon and adopted in the existing system and more importantly how the improvement will be continuous after the assessment team (change agents) leave the company. The technique that we selected for this purpose is called Improvement KATA [2] . The KATA idea, which comes from Japanese martial arts, means habits or patterns of thinking that are being conducted by an individual and practiced every day [2] . Improvement KATA is a general-purpose framework including a set of practices for reaching goals where the path to the goal is uncertain. Improvement KATA provides an experimental approach with a 4 step pattern: 1) Understand the direction or challenge, 2) Grasp the current condition, 3) Establish the next target condition and 4) Iterate towards the target condition [49] . In process improvement, the experimental approach for finding the right practices and figuring out the ways to implement them is very important so that the companies do not over invest in a solution that will not work for them. The challenge of investing in the right improvement practices for the right time could only be achieved with the help of an experimental approach.
Following an MDevSPICE ® based process assessment, we introduce companies to the Improvement KATA framework and the KATA document templates to be used in the process. 
Some parts of this
Improvement and Re-assessments:
We implement the changes in an iterative and incremental way and follow the progress. Besides, to ensure the conformance to regulatory standards, we re-assess the software projects.
IMPLEMENTATION of the APPROACH via ACTION RESEARCH
We have implemented the Hybrid Assessment Approach which includes the following subsections described above: software process assessments based on MDevSPICE ® (Section 6.2, Part (A)), prioritizations and value stream mappings (Section 6.2, Part (B)) and Improvement KATA approach (Section 6.2, Part (C)). Even though we have started improving the processes of the companies, the project is not in the re-assessment phase yet.
Based on the characteristics of this research, the best qualitative approach that suits the needs of the research is action research which associates theory and practice. In the action research, the practice is informed by the research and the research is informed by the practice synergistically [58] . "Action research is an iterative process involving researchers and practitioners acting together on a particular cycle of activities, including problem diagnosis, action intervention, and reflective learning" [58] . The purpose of implementing the proposed approach is to show the applicability of this approach in the medical device software development industry. Thus, we implemented the research in four different companies three of which are from medical device development domain and one of them is a software development organization that is planning to develop software that could in the future be classified as a medical device and therefore also wants to implement MDevSPICE ® as a process improvement framework.
Overview of the Companies and Planning
The selected companies approached us with the purpose of improving their software processes while ensuring regulatory requirements. After initial negotiations, they agreed to be a part of the study. In paragraph below, we briefly describe each participating company. In the planning phase, for each organization we have decided the type of the project and number of the processes that will take place in the process assessment, the dates of the assessment and the staff that will be included in the assessment.
Initially, we planned 1 full day of low level assessments for the major software life cycle processes with each company, 2 full days of off-site study for evaluation of the findings and report preparation and a further half day for the onsite findings' briefing presentation (for each company). We selected 10 processes to be assessed which were Project Planning, Project
Monitoring, Stakeholder Requirements, System Requirements Analysis, System Architectural Design, Software Requirements Analysis, Software Architectural Design, Software Unit Implementation and Testing, Software Integration and Testing, Software System Testing. Prior to assessments, we defined a detailed set of assessment questions based on MDevSPICE ® base practices. For value stream, prioritization and KATA studies, we prepared the templates.
Implementation of the Action Research within the Companies
We performed onsite visits to organisations for assessments. Two/three assessors were involved in each assessment, one asking scripted interview questions whilst the others took notes. In Table 3 , we listed the roles of the interviewed staff, the total interview hours, types of assessed projects, and the assessed processes. The assessed processes diverged slightly from those planned for Companies A and B. Instead of the planned 10 processes, we actually assessed 7
for Company A and 6 for Company B due to the time required to ask the large number of assessment questions combined with observing the supporting evidence, as we operated within a fixed time for the assessment. The assessments within Companies A and B process were then followed by prioritization (including value stream mapping studies) and as planned. However, due to limited number of the assessed processes, we couldn't establish an overall view of the issues and problems in the projects within these assessments which had an significant impact on the prioritization phase. With the experiences obtained from the Company A and Company B process assessments, we consequently changed the assessment plan, and decided to perform a holistic assessment with 23 processes at a higher level (with less scripted questions). We reviewed all the assessment questions and defined 3 to 5 questions for each process which were more focused and open ended. For example, for system requirements analysis process, we asked the following four questions:
-What types of component/interfaces do you have?
-How do you define your system requirements?
-Do you make use of a traceability matrix?
-What challenges do you face in relation to the system requirements analysis process?
For each process, we repeated the last question given above for each of the 23 processes, in order to figure out the challenges that they faced.
In the value stream mapping studies, we discussed the major activities within the software development life cycle process, the lead times and percentage of rework required for these activities by the teams.
For Company A and Company B, the assessment team went offsite and worked as a team to prepare the assessment findings reports. Within the findings phase, in addition to identifying strengths and gaps, we also listed improvement action suggestions to address the issues. Due to time scheduling difficulties it took more than two months for the assessment team to meet with
Company A and B again on their premises to present the findings presentation. In order to achieve this in a more effective way, we changed the plan and extended our onsite stay for
Company C and Company D, and presented the high-level findings for all 23 processes within the same week.
The presentation of the findings and value stream mappings were followed by prioritization of the issues. We also presented how the improvement actions to resolves the identified issues could be implemented and presented the Improvement KATA approach to the development teams within each of the 4 companies. All 4 companies expressed excitement about the approach and liked the idea of implementing some initial actions to better determine if the suggested practices would work for them or not.
Findings of the Action Research
In this sub-section, we provide the findings of the action research in three parts: (a) common or specific issues that were found when performing the assessments, Below, we have discussed the issues that were either common or specific to the four companies and our suggestions for resolving the issues. The issues listed here were identified through both conducting interviews and observing project artifacts during the onsite visits. We asked detailed, pre-defined questions during the onsite interviews for each base practice in MDevSPICE ® to the process owners.
It was observed that Company A, B and C did not make use of formal project plans, project timelines or schedules. Progress against project objectives is not signed off. Knowledge is not transferred efficiently between projects. In terms of estimation, there is no size estimation of software but effort estimation is performed in an Ad-Hoc way.
We also found that customer involvement was quite limited within all the projects we assessed in the four companies. This creates accuracy and ambiguity problems in relation to captured requirements and as a result of this, rework was frequently required.
We discovered in all four companies that third party functionality and the risks associated with that functionality at the software requirements, system requirements and software architecture stages were not taken into account and were often overlooked. Special attention is needed to ensure that third party functionality would not introduce safety risks into the medical device.
In medical device development projects, most of the time hardware is part of the system and hardware decisions need to be made at the beginning of the projects, when the system requirements are not very clear. Therefore, system architecture decisions need to be verified not just with drawings but also through code. Proving the architecture with code was not a common practice in the projects we assessed.
Automated tests play a significant role in terms of increasing the confidence of development teams with every change made progressing the development towards achieving higher quality software. For the three projects (A, B and C), the software and the system were manually tested.
Automated unit and regression tests which are essential for continuous integration, have already started to be implemented in Company D as the goal is to achieve continuous delivery in the long term.
(b) Value Stream Mapping
In Figure 2 , we provide an example of a value stream mapping study that we conducted within Company A. In this study, we looked at a feature's life cycle at a deep level and identified LT, PT and C/A%. The VSM study showed that the process time for a feature to complete was 2 weeks and 5 days whereas the lead time is 12.5 weeks. The result of the study made a significant impact on the group showing that there is a 10-week gap between Process Time and Lead Time.
Upon analysis, the reason for the gap was attributed mostly to waiting rather than rework. After the study, requirements elicitation and analysis were selected as the first two areas to work. 
(c) Prioritization
For each company, we provided a list of the issues found during the assessment and presented these issues to relevant parties within the Companies. Given the issues and the differences between process times and lead times in value stream mapping, we were able to focus our attention to critical processes that needs to be treated first.
Three highly connected processes in Company A, B and C which are stakeholder requirements definition, system requirement and software requirements, were selected as the first three processes to be focused. In parallel, it is aimed to establish automated unit test suites in parallel to other improvement studies.
In Company D, we decided to direct our focus on improving the communication among feature/product teams within the program to achieve better results in the areas of requirements management and software architecture, given there might be common or conflicting requirements that will affect the software architecture at the program level. 
CONCLUSION and FUTURE PLANS
Medical device development organizations are seeking ways to be more flexible and adaptive, and ensure that they build safe and high-quality software and comply with the regulatory requirements. Based on both the safety classification and region they wish to market their medical device such organizations need to comply with different types of regulatory standards.
In order to solve the complexity problem regarding compliance to different regulatory standards, we previously developed MDevSPICE ® . Within this paper, we highlighted that whilst MDevSPICE ® works well for companies developing software in a plan driven environment, the recommendations were difficult to implement within an agile development approach. Therefore, to solve this problem, we proposed a hybrid assessment approach. The approach includes the integration of agile practice recommendations with MDevSPICE ® process assessments, then practicing value stream mappings as part of the prioritization phase, and then implementing suggested changes via the Improvement KATA technique.
In this paper, we described the hybrid assessment approach for medical device companies and its implementation in four medical device software development companies. We performed onsite process assessments based on MDevSPICE ® , analyzed their value streams, provided recommendations and prioritized improvement actions in terms of processes using action research. For these four companies, we identified and discussed which processes contained gaps and suggested improvement practices.
Discussions with the assessed companies during the findings presentations reflected that based on the gaps and recommendations we presented to those companies, that the companies were keen to adopt this approach. Therefore, we feel that there is a need to build upon this research.
In future studies with the companies, we will continue implementing agile specific improvement actions in an experimental way and periodically evaluating the progress. Value stream mapping studies will be repeated in three-month intervals to observe improvement in the lead times of the software development life cycle activities.
In terms of the assessment process, we observed that it is more valuable within a short timeframe, to get a higher-level view of the project assessed across more processes, rather than completing a more detailed assessment across fewer processes. As the initial goal of the assessments performed was not for the purpose of preparing companies for regulatory audits but rather for the identification of gaps, and to recommend improvement needs, and for the prioritizations of the future actions.
In terms of refining the hybrid assessment approach, an agile practices repository will be composed to provide two-way traceability between agile practices and MDevSPICE ® base practices. We will be repeating this action research with other medical device software development companies and reflecting upon the lessons learned from the field studies relating to the hybrid assessment approach.
